Literature DB >> 2678805

[A 3-month, randomized double-blind dose-response study with 0-(beta-hydroxyethyl)-rutoside oral solutions].

W Nocker, W Diebschlag, W Lehmacher.   

Abstract

The antioedematous effect of 0-(beta-Hydroxylethyl)-rutoside (HR)-drinking solutions with 600, 900, 1200 and 1500 mg active substance was tested in a randomized double-blind study against placebo with 30 female patients in the change of life. The decrease of the oedemas was measured by recording the change in the leg volume. The patients valued the symptoms "tired and heavy legs", "tenseness" and "tingling sensation". After 3 months the daily taking of HR-drinking solutions showed a significant decrease of leg volume. At the end of the treatment there was no significant difference between the four verum groups.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2678805

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  5 in total

1.  Time course of the anti-oedematous effect of O-(beta-hydroxyethyl)-rutosides in healthy volunteers.

Authors:  D Rehn; G Hennings; W Nocker; W Diebschlag
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Effects of hydroxyethylrutosides on the permeability of microvessels in the frog mesentery.

Authors:  S Kendall; R Towart; C C Michel
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

Review 3.  Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders.

Authors:  A N Wadworth; D Faulds
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

Review 4.  Phlebotonics for venous insufficiency.

Authors:  Maria José Martinez-Zapata; Robin W M Vernooij; Sonia Maria Uriona Tuma; Airton T Stein; Rosa M Moreno; Emilio Vargas; Dolors Capellà; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2016-04-06

5.  Phlebotonics for venous insufficiency.

Authors:  Maria José Martinez-Zapata; Robin Wm Vernooij; Daniel Simancas-Racines; Sonia Maria Uriona Tuma; Airton T Stein; Rosa Maria M Moreno Carriles; Emilio Vargas; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2020-11-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.